Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
    • GP-001 Documents and records control
      • Deprecated
      • Brazil
      • Legacy MDD
        • R-001-002 Manufacturer declaration of conformity
        • R-TF-001-006 IFU and Label Validation - Legacy MDD Device
      • R-001-001 Control of documents
      • R-001-003 List of external documents
    • GP-002 Quality planning
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 HR and training
    • GP-007 Post-market surveillance
    • GP-009 Sales
    • GP-010 Suppliers
    • GP-011 Provision of service
    • GP-012 Design, Redesign and Development
    • GP-018 Infrastructure and facilities
    • GP-019 Non-product software validation
    • GP-023 Change control management
    • GP-031 Training Data Governance
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
    • GP-110 Esquema Nacional de Seguridad
    • GP-200 Remote Data Acquisition in Clinical Investigations
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
  • Pricing
  • Public tenders
  • Records
  • GP-001 Documents and records control
  • Legacy MDD
  • R-TF-001-006 IFU and Label Validation - Legacy MDD Device

R-TF-001-006 IFU and Label Validation - Legacy MDD Device

  • Governed by GP-001 Document and Records Control
Record creation context

This record was created on 2026-03-08 as part of the corrective action for BSI Surveillance Audit 2026 (NCR 5 - Finding Reference: 2780856-202603-N5). The validation was performed retroactively to formally document the verification of IFU and Label for the Legacy MDD Class I device against the approved technical documentation.

Medical device​

Product information
Product or trade nameLegit.Health
Product version2.1
EUDAMED IDD-Legit.Health8U
SRNES-MF-000025345
Reference/CatalogueLegit.Health
ClassClass I (Rule 12) per MDD 93/42/EEC
Regulatory frameworkCouncil Directive 93/42/EEC (MDD)
DeclarationR-001-002 Manufacturer declaration of conformity (signed by Andy Aguilar, 2023-03-07)

Label validation​

The label validation has been performed in accordance with Council Directive 93/42/EEC (MDD), Annex I, Section 13 requirements for labelling of medical devices.

The label for the Legacy MDD device is published at: https://apidocs.legit.health/

RequirementValidationNotes
The name or trade name of the device.✅"Legit.Health" - Displayed in the label
The name or trade name and address of the manufacturer.✅AI Labs Group SL, Gran Vía 1, BAT Tower, 48001 Bilbao, Bizkaia, Spain
The details strictly necessary to identify the device and the contents of the packaging.✅Software device - no physical packaging. Version and identification provided.
The lot number or the serial number of the device.✅Version 2.1 serves as identification for this software device
The UDI code.N/AUDI-DI not required for self-declared MDD Class I devices placed on market before 26 May 2021
The special storage and/or handling conditions.✅Cloud-based software - no special storage conditions apply
Any special operating instructions.✅Refer to IFU for operating instructions
Any warnings and/or precautions to take.✅Included in IFU - device for diagnostic support only, not for standalone diagnosis
Manufacture date.✅Initial release 2020, current version 2023
If the intended purpose of the device is not obvious to the user, it must be clearly stated.✅Intended purpose clearly stated: support HCPs in assessment of skin structures
An indication that the device is a medical device.✅CE marking displayed with Class I indication per MDD 93/42/EEC

Label evidence​

The label is accessible at https://apidocs.legit.health/ and includes:

  • CE marking for Class I medical device under MDD 93/42/EEC
  • Manufacturer identification
  • Product name and version
  • Intended purpose statement
  • Reference to Instructions for Use

IFU validation​

The validation of the Instructions for Use was performed in accordance with Council Directive 93/42/EEC (MDD), Annex I, Section 13 and the essential requirements applicable to Class I medical devices.

The IFU for the Legacy MDD device is published at: https://apidocs.legit.health/

RequirementValidationNotes
The name or trade name of the device.✅"Legit.Health" - Displayed throughout the IFU
The name or trade name and address of the manufacturer.✅AI Labs Group SL, Gran Vía 1, BAT Tower, 48001 Bilbao, Bizkaia, Spain
The details strictly necessary to identify the device and the contents of the packaging especially for the users.✅Software identification, version, and technical specifications provided
The special storage and/or handling conditions.✅Cloud-based software - no special storage conditions
Any special operating instructions.✅API integration instructions, authentication, and usage guidelines provided
Any warnings and/or precautions to take.✅Warnings about diagnostic support nature, professional use only, contraindications
Device's intended purpose with a clear specification of indications, contra-indications, targeted patients and intended users.✅Intended purpose: support HCPs in assessment of skin structures; intended users: HCPs
The classification of the device according to the applicable standards.✅Class I per MDD 93/42/EEC, Rule 12
Warning for any undesirable side effects.✅Not applicable - software device with no direct patient contact
All information needed to verify whether the device can operate correctly and safely, with details of the nature and frequency of the maintenance to ensure safety and performance.✅Technical requirements, system compatibility, and maintenance information provided
Information regarding the risks of reciprocal interference posed by the presence of the device during specific treatment.N/ANot applicable - standalone software with no interaction with treatment devices
Any contra-indications or precautions to be taken for the device safety use and performance.✅Contraindications and precautions documented in IFU
Date of issue of the instructions for use.✅Version history with dates maintained in the IFU
A notice to the user and/or patient that any serious incident that has occurred in relation to the device should be reported to the manufacturer and the competent national authority.✅Incident reporting instructions provided with manufacturer contact: support@legit.health

Verification against EUDAMED registration​

The following verification was performed to ensure consistency between the published IFU/Label and the EUDAMED registration:

EUDAMED FieldEUDAMED ValueIFU/Label ValueMatch
EUDAMED ID codeD-Legit.Health8UD-Legit.Health8U✅
SRNES-MF-000025345ES-MF-000025345✅
Name/Trade nameLegit.HealthLegit.Health✅
Reference/Catalogue numberLegit.HealthLegit.Health✅
Manufacturer nameAI Labs Group SLAI Labs Group SL✅
Device classificationClass I (MDD 93/42/EEC)Class I (MDD 93/42/EEC)✅

Verification against Declaration of Conformity​

The published IFU and Label information was verified against the Declaration of Conformity (R-001-002):

Declaration FieldDeclaration ValueIFU/Label ValueMatch
Product nameLegit.HealthLegit.Health✅
Product version2.12.1✅
ClassificationClass I (Rule 12)Class I (Rule 12)✅
Regulatory frameworkCouncil Directive 93/42/EECCouncil Directive 93/42/EEC✅
ManufacturerAI Labs Group SL, Gran Vía 1, BAT Tower, 48001 BilbaoAI Labs Group SL, Gran Vía 1, BAT Tower, 48001 Bilbao✅

Conclusion​

The IFU and Label for the Legacy MDD device (Legit.Health version 2.1) have been verified and validated against:

  1. The requirements of Council Directive 93/42/EEC (MDD), Annex I, Section 13
  2. The EUDAMED registration (ES-MF-000025345, D-Legit.Health8U)
  3. The Declaration of Conformity (R-001-002)

All required elements are present and consistent across all documentation sources.

Validation performed by​

FieldValue
Validated bySaray Ugidos Seman
PositionRegulatory Affairs Manager
Validation date2026-03-08
Validation methodDocument review and cross-reference verification

Signature meaning

The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:

  • Author: Team members involved
  • Reviewer: JD-003 Design & Development Manager, JD-004 Quality Manager & PRRC
  • Approver: JD-001 General Manager
ㅤ ㅤ

Previous
R-001-002 Manufacturer declaration of conformity
Next
R-001-001 Control of documents
  • Medical device
  • Label validation
    • Label evidence
  • IFU validation
  • Verification against EUDAMED registration
  • Verification against Declaration of Conformity
  • Conclusion
  • Validation performed by
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)